Efficacy of Fetal Ear Length as a Prenatal Marker of Chromosomal Anomalies: A Prospective, Multicenter Cohort Study in a Southern European Population.
Por:
Baldrich E, Comas M, Maldonado A, Blasco M, Manresa-Domínguez JM, Iniguez-Cruz M and Borrell A
Publicada:
1 ene 2026
Ahead of Print:
14 ago 2025
Resumen:
OBJECTIVE: To develop a nomogram of fetal ear length (FEL) by gestational age in a healthy pregnant Southern European population and assess its potential as a prenatal ultrasound marker of chromosomal anomalies in this demographic. METHODS: This prospective, multicenter cohort study included low-risk pregnancies from 11 + 2 to 34 + 6 gestational age. A nomogram was constructed based on gestational age for healthy fetuses with normal perinatal outcomes. Intraobserver and interobserver reliability were evaluated. To assess the efficacy of FEL as a marker of chromosomal anomalies, a multivariate logistic regression analysis was performed; sensitivity and specificity were calculated. RESULTS: A total of 1923 FEL measurements were obtained from 1331 singleton pregnancies. Using data from healthy fetuses, a nomogram was constructed through linear regression analysis. Measurement feasibility was excellent, with intra- and interobserver correlation coefficients of 0.996 (95% confidence interval [CI]: 0.995-0.997) and 0.998 (95% CI: 0.978-0.999), respectively. FEL achieved a sensitivity of 81.8% and a specificity of 49.8% in detecting chromosomal anomalies. Multivariate logistic regression indicated that FEL = 5th percentile significantly increased the likelihood of detecting chromosomal anomalies (odds ratio = 3.11); although the wide 95% CI (1.92-10.7) suggests a cautious interpretation of this finding. CONCLUSIONS: While FEL demonstrates potential as a prenatal marker of chromosomal anomalies, its clinical utility remains limited due to moderate sensitivity and specificity. Further studies are warranted to refine its diagnostic value in routine screening practices.
Filiaciones:
Baldrich E:
Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain
Research Group on Sexual and Reproductive Healthcare (GRASSIR) (2021-SGR-793), Barcelona, Spain
Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain
Comas M:
Gynecology and Obstetrics Service, Parc Tauli University Hospital, Parc Taulí Research and Innovation Institute (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Catalonia, Spain
Maldonado A:
Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain
Blasco M:
Obstetrics and Gynecology Primary Care Center (ASSIR) Sabadell, Institut Catala de la Salut, Barcelona, Spain
:
Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Catalonia, Spain
Iniguez-Cruz M:
Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, Catalonia, Spain
Borrell A:
Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain
BCNatal Barcelona Centre for Maternal-Fetal and Neonatal Medicine (BCNatal), Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona, Catalonia, Spain
|